NNOX Nano-X Imaging Ltd. Annual reports only
X-Ray Apparatus & Tubes & Related Irradiation Apparatus · Nasdaq · SEC CIK 1795251 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY15.4%
TTM net income YoY-40.2%
TTM EPS YoY-27.5%
Revenue 3-yr CAGR14.9%
Net income 3-yr CAGR—
Margins
Gross margin-98.2%
Operating margin-600.8%
Net margin-576.1%
FCF margin-345.6%
EBITDA margin-591.7%
Returns
ROE-45.6%
ROA-40.3%
ROIC (approx.)-51.4%
Asset turnover0.07x
Leverage & solvency
Liabilities / assets13.8%
Debt / equity0.00x
Current ratio3.96x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.54x
Accruals ratio-18.4%
Payout ratio—
Capex / revenue32.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $13.02M | $11.28M |
| Cost of revenue | $25.81M | $21.89M |
| Gross profit | -$12.79M | -$10.61M |
| R&D expense | $19.24M | $20.18M |
| SG&A expense | $21.59M | $22.45M |
| Operating income | -$78.23M | -$56.75M |
| Pretax income | -$76.81M | -$53.87M |
| Income tax | -$1.79M | -$358,000 |
| Net income | -$75.02M | -$53.52M |
| EBITDA | -$77.05M | -$55.62M |
| EPS (basic) | -1.16 | -0.91 |
| EPS (diluted) | -1.16 | -0.91 |
| Weighted avg. shares (diluted) | 64,790 | 58,673 |
| Balance sheet | ||
| Cash & equivalents | $49.15M | $39.30M |
| Short-term investments | — | $18.40M |
| Inventory | $3.07M | $1.49M |
| Current assets | $66.79M | $78.68M |
| PP&E, net | $29.68M | $45.35M |
| Goodwill | $316,000 | — |
| Intangibles | $59.87M | $70.00M |
| Total assets | $162.16M | $210.00M |
| Current liabilities | $16.89M | $13.97M |
| Short-term debt | $3.14M | $3.06M |
| Total liabilities | $22.43M | $20.88M |
| Shareholders' equity | $139.73M | $189.12M |
| Cash flow statement | ||
| Operating cash flow | -$40.79M | -$36.60M |
| Capital expenditure | $4.21M | $2.77M |
| Free cash flow | -$45.00M | -$39.37M |
| Investing cash flow | $29.37M | -$20.05M |
| Financing cash flow | $21.37M | $39.50M |
| Depreciation & amortization | $1.19M | $1.12M |
| Stock-based compensation | $4.19M | $7.26M |
Free plan shows the latest 2 periods; Pro shows all 8 🔒
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.